Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vocan Biotechnologies
Victoria, British Columbia, Canada
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Vocan Biotechnologies develops genetic engineering and biosynthesis technology to produce cGMP API-grade psilocybin (and other psychedelic compounds such as DMT) via an optimized microbial fermentation process, with successful proof-of-concept for biosynthetic psilocybin and a patent application titled “Production of Psychedelic Compounds”; the company focuses on supplying pharmaceutical-grade psychedelic APIs rather than running its own clinical trials.[1][2][3][5]
- Therapeutic areas
- Psychiatry
- Modalities
- Small molecule
- Industry
- Non-Drug Biotech
02
Partnerships
Core One Labs (vertical integration for psychedelic medicines development and delivery)
Beyond the preview
Go deeper on Vocan Biotechnologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vocan Biotechnologies.